nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—Lisinopril—dilated cardiomyopathy	0.12	0.532	CbGbCtD
Citalopram—ABCB1—Spironolactone—dilated cardiomyopathy	0.106	0.468	CbGbCtD
Citalopram—Neck pain—Lisinopril—dilated cardiomyopathy	0.00223	0.00315	CcSEcCtD
Citalopram—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00223	0.00315	CcSEcCtD
Citalopram—Purpura—Furosemide—dilated cardiomyopathy	0.00221	0.00313	CcSEcCtD
Citalopram—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0022	0.00312	CcSEcCtD
Citalopram—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.0022	0.00312	CcSEcCtD
Citalopram—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00219	0.0031	CcSEcCtD
Citalopram—Lethargy—Furosemide—dilated cardiomyopathy	0.00217	0.00308	CcSEcCtD
Citalopram—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00215	0.00304	CcSEcCtD
Citalopram—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00214	0.00303	CcSEcCtD
Citalopram—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00214	0.00303	CcSEcCtD
Citalopram—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00214	0.00303	CcSEcCtD
Citalopram—Wheezing—Lisinopril—dilated cardiomyopathy	0.00214	0.00303	CcSEcCtD
Citalopram—Malaise—Spironolactone—dilated cardiomyopathy	0.00213	0.00301	CcSEcCtD
Citalopram—Cystitis—Lisinopril—dilated cardiomyopathy	0.00213	0.00301	CcSEcCtD
Citalopram—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00211	0.00299	CcSEcCtD
Citalopram—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00209	0.00296	CcSEcCtD
Citalopram—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00207	0.00293	CcSEcCtD
Citalopram—Photophobia—Lisinopril—dilated cardiomyopathy	0.00207	0.00293	CcSEcCtD
Citalopram—Irritability—Furosemide—dilated cardiomyopathy	0.00203	0.00288	CcSEcCtD
Citalopram—Urinary retention—Furosemide—dilated cardiomyopathy	0.00203	0.00287	CcSEcCtD
Citalopram—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00199	0.00282	CcSEcCtD
Citalopram—Discomfort—Spironolactone—dilated cardiomyopathy	0.00198	0.00281	CcSEcCtD
Citalopram—Dehydration—Furosemide—dilated cardiomyopathy	0.00198	0.0028	CcSEcCtD
Citalopram—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00197	0.00279	CcSEcCtD
Citalopram—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00195	0.00275	CcSEcCtD
Citalopram—Confusional state—Spironolactone—dilated cardiomyopathy	0.00194	0.00275	CcSEcCtD
Citalopram—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00194	0.00274	CcSEcCtD
Citalopram—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00193	0.00273	CcSEcCtD
Citalopram—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00192	0.00272	CcSEcCtD
Citalopram—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00192	0.00272	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00192	0.00272	CcSEcCtD
Citalopram—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00188	0.00267	CcSEcCtD
Citalopram—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00188	0.00266	CcSEcCtD
Citalopram—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00185	0.00262	CcSEcCtD
Citalopram—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.00261	CcSEcCtD
Citalopram—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00184	0.0026	CcSEcCtD
Citalopram—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00182	0.00258	CcSEcCtD
Citalopram—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0018	0.00256	CcSEcCtD
Citalopram—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0018	0.00255	CcSEcCtD
Citalopram—Eczema—Lisinopril—dilated cardiomyopathy	0.00178	0.00252	CcSEcCtD
Citalopram—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00178	0.00252	CcSEcCtD
Citalopram—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00177	0.00251	CcSEcCtD
Citalopram—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00175	0.00248	CcSEcCtD
Citalopram—Injury—Lisinopril—dilated cardiomyopathy	0.00174	0.00246	CcSEcCtD
Citalopram—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00173	0.00245	CcSEcCtD
Citalopram—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00172	0.00244	CcSEcCtD
Citalopram—Somnolence—Spironolactone—dilated cardiomyopathy	0.00171	0.00242	CcSEcCtD
Citalopram—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0017	0.00241	CcSEcCtD
Citalopram—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00169	0.00239	CcSEcCtD
Citalopram—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00168	0.00238	CcSEcCtD
Citalopram—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00166	0.00235	CcSEcCtD
Citalopram—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00166	0.00235	CcSEcCtD
Citalopram—Arthritis—Lisinopril—dilated cardiomyopathy	0.00164	0.00233	CcSEcCtD
Citalopram—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00164	0.00232	CcSEcCtD
Citalopram—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00163	0.00231	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00163	0.0023	CcSEcCtD
Citalopram—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0016	0.00227	CcSEcCtD
Citalopram—Diplopia—Lisinopril—dilated cardiomyopathy	0.0016	0.00226	CcSEcCtD
Citalopram—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0016	0.00226	CcSEcCtD
Citalopram—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.0016	0.00226	CcSEcCtD
Citalopram—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00159	0.00224	CcSEcCtD
Citalopram—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00159	0.00224	CcSEcCtD
Citalopram—Sweating—Furosemide—dilated cardiomyopathy	0.00157	0.00223	CcSEcCtD
Citalopram—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00155	0.0022	CcSEcCtD
Citalopram—Face oedema—Lisinopril—dilated cardiomyopathy	0.00154	0.00218	CcSEcCtD
Citalopram—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00153	0.00217	CcSEcCtD
Citalopram—Urticaria—Spironolactone—dilated cardiomyopathy	0.00153	0.00216	CcSEcCtD
Citalopram—Irritability—Lisinopril—dilated cardiomyopathy	0.00153	0.00216	CcSEcCtD
Citalopram—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00152	0.00215	CcSEcCtD
Citalopram—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00152	0.00215	CcSEcCtD
Citalopram—Ataxia—Lisinopril—dilated cardiomyopathy	0.0015	0.00213	CcSEcCtD
Citalopram—Dehydration—Lisinopril—dilated cardiomyopathy	0.00149	0.0021	CcSEcCtD
Citalopram—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00146	0.00207	CcSEcCtD
Citalopram—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00145	0.00206	CcSEcCtD
Citalopram—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00144	0.00204	CcSEcCtD
Citalopram—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00144	0.00204	CcSEcCtD
Citalopram—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00144	0.00204	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00144	0.00204	CcSEcCtD
Citalopram—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00143	0.00202	CcSEcCtD
Citalopram—Visual impairment—Furosemide—dilated cardiomyopathy	0.00142	0.00201	CcSEcCtD
Citalopram—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00142	0.00201	CcSEcCtD
Citalopram—Gastritis—Lisinopril—dilated cardiomyopathy	0.00141	0.002	CcSEcCtD
Citalopram—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00139	0.00197	CcSEcCtD
Citalopram—Asthma—Lisinopril—dilated cardiomyopathy	0.00138	0.00196	CcSEcCtD
Citalopram—Influenza—Lisinopril—dilated cardiomyopathy	0.00138	0.00196	CcSEcCtD
Citalopram—Eye disorder—Furosemide—dilated cardiomyopathy	0.00138	0.00195	CcSEcCtD
Citalopram—Tinnitus—Furosemide—dilated cardiomyopathy	0.00137	0.00194	CcSEcCtD
Citalopram—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00137	0.00194	CcSEcCtD
Citalopram—Pruritus—Spironolactone—dilated cardiomyopathy	0.00136	0.00193	CcSEcCtD
Citalopram—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00136	0.00192	CcSEcCtD
Citalopram—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00135	0.00192	CcSEcCtD
Citalopram—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00135	0.0019	CcSEcCtD
Citalopram—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00135	0.0019	CcSEcCtD
Citalopram—Angiopathy—Furosemide—dilated cardiomyopathy	0.00134	0.00189	CcSEcCtD
Citalopram—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00133	0.00188	CcSEcCtD
Citalopram—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00133	0.00188	CcSEcCtD
Citalopram—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00132	0.00186	CcSEcCtD
Citalopram—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00132	0.00186	CcSEcCtD
Citalopram—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00131	0.00186	CcSEcCtD
Citalopram—Dysuria—Lisinopril—dilated cardiomyopathy	0.00129	0.00183	CcSEcCtD
Citalopram—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00128	0.00182	CcSEcCtD
Citalopram—Erythema—Furosemide—dilated cardiomyopathy	0.00128	0.00182	CcSEcCtD
Citalopram—Malnutrition—Furosemide—dilated cardiomyopathy	0.00128	0.00182	CcSEcCtD
Citalopram—Dizziness—Spironolactone—dilated cardiomyopathy	0.00127	0.0018	CcSEcCtD
Citalopram—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00127	0.0018	CcSEcCtD
Citalopram—Flatulence—Furosemide—dilated cardiomyopathy	0.00126	0.00179	CcSEcCtD
Citalopram—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00126	0.00178	CcSEcCtD
Citalopram—Weight increased—Lisinopril—dilated cardiomyopathy	0.00126	0.00178	CcSEcCtD
Citalopram—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00126	0.00178	CcSEcCtD
Citalopram—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00125	0.00177	CcSEcCtD
Citalopram—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00125	0.00176	CcSEcCtD
Citalopram—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00124	0.00175	CcSEcCtD
Citalopram—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00123	0.00175	CcSEcCtD
Citalopram—Depression—Lisinopril—dilated cardiomyopathy	0.00123	0.00174	CcSEcCtD
Citalopram—Vomiting—Spironolactone—dilated cardiomyopathy	0.00122	0.00173	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00122	0.00173	CcSEcCtD
Citalopram—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00121	0.00172	CcSEcCtD
Citalopram—Rash—Spironolactone—dilated cardiomyopathy	0.00121	0.00172	CcSEcCtD
Citalopram—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00121	0.00172	CcSEcCtD
Citalopram—Vision blurred—Furosemide—dilated cardiomyopathy	0.00121	0.00171	CcSEcCtD
Citalopram—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00121	0.00171	CcSEcCtD
Citalopram—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00121	0.00171	CcSEcCtD
Citalopram—Headache—Spironolactone—dilated cardiomyopathy	0.00121	0.00171	CcSEcCtD
Citalopram—Jaundice—Lisinopril—dilated cardiomyopathy	0.0012	0.0017	CcSEcCtD
Citalopram—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.0012	0.00169	CcSEcCtD
Citalopram—Anaemia—Furosemide—dilated cardiomyopathy	0.00119	0.00168	CcSEcCtD
Citalopram—Sweating—Lisinopril—dilated cardiomyopathy	0.00118	0.00167	CcSEcCtD
Citalopram—Agitation—Furosemide—dilated cardiomyopathy	0.00118	0.00167	CcSEcCtD
Citalopram—Haematuria—Lisinopril—dilated cardiomyopathy	0.00117	0.00166	CcSEcCtD
Citalopram—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00116	0.00165	CcSEcCtD
Citalopram—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00116	0.00164	CcSEcCtD
Citalopram—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00116	0.00164	CcSEcCtD
Citalopram—Vertigo—Furosemide—dilated cardiomyopathy	0.00115	0.00163	CcSEcCtD
Citalopram—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00115	0.00163	CcSEcCtD
Citalopram—Leukopenia—Furosemide—dilated cardiomyopathy	0.00115	0.00163	CcSEcCtD
Citalopram—Nausea—Spironolactone—dilated cardiomyopathy	0.00114	0.00162	CcSEcCtD
Citalopram—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00113	0.00159	CcSEcCtD
Citalopram—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00111	0.00157	CcSEcCtD
Citalopram—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00111	0.00157	CcSEcCtD
Citalopram—Hallucination—Lisinopril—dilated cardiomyopathy	0.0011	0.00156	CcSEcCtD
Citalopram—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.0011	0.00155	CcSEcCtD
Citalopram—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00109	0.00155	CcSEcCtD
Citalopram—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00109	0.00154	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00108	0.00154	CcSEcCtD
Citalopram—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00108	0.00153	CcSEcCtD
Citalopram—Dry mouth—Furosemide—dilated cardiomyopathy	0.00107	0.00151	CcSEcCtD
Citalopram—Confusional state—Furosemide—dilated cardiomyopathy	0.00106	0.00149	CcSEcCtD
Citalopram—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00105	0.00148	CcSEcCtD
Citalopram—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00105	0.00148	CcSEcCtD
Citalopram—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00103	0.00146	CcSEcCtD
Citalopram—Shock—Furosemide—dilated cardiomyopathy	0.00103	0.00146	CcSEcCtD
Citalopram—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00103	0.00145	CcSEcCtD
Citalopram—Flushing—Lisinopril—dilated cardiomyopathy	0.00103	0.00145	CcSEcCtD
Citalopram—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00102	0.00145	CcSEcCtD
Citalopram—Skin disorder—Furosemide—dilated cardiomyopathy	0.00102	0.00144	CcSEcCtD
Citalopram—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00101	0.00143	CcSEcCtD
Citalopram—Angiopathy—Lisinopril—dilated cardiomyopathy	0.001	0.00142	CcSEcCtD
Citalopram—Anorexia—Furosemide—dilated cardiomyopathy	0.000998	0.00141	CcSEcCtD
Citalopram—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000996	0.00141	CcSEcCtD
Citalopram—Chills—Lisinopril—dilated cardiomyopathy	0.000992	0.0014	CcSEcCtD
Citalopram—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000988	0.0014	CcSEcCtD
Citalopram—Hypotension—Furosemide—dilated cardiomyopathy	0.000978	0.00138	CcSEcCtD
Citalopram—Alopecia—Lisinopril—dilated cardiomyopathy	0.000977	0.00138	CcSEcCtD
Citalopram—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000968	0.00137	CcSEcCtD
Citalopram—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000962	0.00136	CcSEcCtD
Citalopram—Erythema—Lisinopril—dilated cardiomyopathy	0.000962	0.00136	CcSEcCtD
Citalopram—Flatulence—Lisinopril—dilated cardiomyopathy	0.000948	0.00134	CcSEcCtD
Citalopram—Tension—Lisinopril—dilated cardiomyopathy	0.000944	0.00134	CcSEcCtD
Citalopram—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000942	0.00133	CcSEcCtD
Citalopram—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00094	0.00133	CcSEcCtD
Citalopram—Nervousness—Lisinopril—dilated cardiomyopathy	0.000935	0.00132	CcSEcCtD
Citalopram—Back pain—Lisinopril—dilated cardiomyopathy	0.000931	0.00132	CcSEcCtD
Citalopram—Somnolence—Furosemide—dilated cardiomyopathy	0.000931	0.00132	CcSEcCtD
Citalopram—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000925	0.00131	CcSEcCtD
Citalopram—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00091	0.00129	CcSEcCtD
Citalopram—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000907	0.00128	CcSEcCtD
Citalopram—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000904	0.00128	CcSEcCtD
Citalopram—Fatigue—Furosemide—dilated cardiomyopathy	0.000902	0.00128	CcSEcCtD
Citalopram—Tremor—Lisinopril—dilated cardiomyopathy	0.000902	0.00128	CcSEcCtD
Citalopram—Pain—Furosemide—dilated cardiomyopathy	0.000895	0.00127	CcSEcCtD
Citalopram—Constipation—Furosemide—dilated cardiomyopathy	0.000895	0.00127	CcSEcCtD
Citalopram—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000893	0.00126	CcSEcCtD
Citalopram—Anaemia—Lisinopril—dilated cardiomyopathy	0.000889	0.00126	CcSEcCtD
Citalopram—Angioedema—Lisinopril—dilated cardiomyopathy	0.000879	0.00124	CcSEcCtD
Citalopram—Malaise—Lisinopril—dilated cardiomyopathy	0.000868	0.00123	CcSEcCtD
Citalopram—Vertigo—Lisinopril—dilated cardiomyopathy	0.000865	0.00122	CcSEcCtD
Citalopram—Syncope—Lisinopril—dilated cardiomyopathy	0.000863	0.00122	CcSEcCtD
Citalopram—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000863	0.00122	CcSEcCtD
Citalopram—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000861	0.00122	CcSEcCtD
Citalopram—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000856	0.00121	CcSEcCtD
Citalopram—Palpitations—Lisinopril—dilated cardiomyopathy	0.00085	0.0012	CcSEcCtD
Citalopram—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000846	0.0012	CcSEcCtD
Citalopram—Cough—Lisinopril—dilated cardiomyopathy	0.00084	0.00119	CcSEcCtD
Citalopram—Urticaria—Furosemide—dilated cardiomyopathy	0.000832	0.00118	CcSEcCtD
Citalopram—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000827	0.00117	CcSEcCtD
Citalopram—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000827	0.00117	CcSEcCtD
Citalopram—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000819	0.00116	CcSEcCtD
Citalopram—Chest pain—Lisinopril—dilated cardiomyopathy	0.000819	0.00116	CcSEcCtD
Citalopram—Myalgia—Lisinopril—dilated cardiomyopathy	0.000819	0.00116	CcSEcCtD
Citalopram—Anxiety—Lisinopril—dilated cardiomyopathy	0.000816	0.00116	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000814	0.00115	CcSEcCtD
Citalopram—Discomfort—Lisinopril—dilated cardiomyopathy	0.000809	0.00115	CcSEcCtD
Citalopram—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000801	0.00113	CcSEcCtD
Citalopram—Confusional state—Lisinopril—dilated cardiomyopathy	0.000792	0.00112	CcSEcCtD
Citalopram—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000785	0.00111	CcSEcCtD
Citalopram—Oedema—Lisinopril—dilated cardiomyopathy	0.000785	0.00111	CcSEcCtD
Citalopram—Infection—Lisinopril—dilated cardiomyopathy	0.00078	0.0011	CcSEcCtD
Citalopram—Shock—Lisinopril—dilated cardiomyopathy	0.000773	0.00109	CcSEcCtD
Citalopram—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000771	0.00109	CcSEcCtD
Citalopram—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000769	0.00109	CcSEcCtD
Citalopram—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000767	0.00109	CcSEcCtD
Citalopram—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000763	0.00108	CcSEcCtD
Citalopram—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000759	0.00107	CcSEcCtD
Citalopram—Asthenia—Furosemide—dilated cardiomyopathy	0.000751	0.00106	CcSEcCtD
Citalopram—Anorexia—Lisinopril—dilated cardiomyopathy	0.000749	0.00106	CcSEcCtD
Citalopram—Pruritus—Furosemide—dilated cardiomyopathy	0.000741	0.00105	CcSEcCtD
Citalopram—Hypotension—Lisinopril—dilated cardiomyopathy	0.000734	0.00104	CcSEcCtD
Citalopram—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000716	0.00101	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000716	0.00101	CcSEcCtD
Citalopram—Insomnia—Lisinopril—dilated cardiomyopathy	0.00071	0.00101	CcSEcCtD
Citalopram—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000705	0.000998	CcSEcCtD
Citalopram—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0007	0.000991	CcSEcCtD
Citalopram—Somnolence—Lisinopril—dilated cardiomyopathy	0.000698	0.000989	CcSEcCtD
Citalopram—Dizziness—Furosemide—dilated cardiomyopathy	0.000692	0.00098	CcSEcCtD
Citalopram—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000691	0.000979	CcSEcCtD
Citalopram—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000683	0.000967	CcSEcCtD
Citalopram—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000678	0.00096	CcSEcCtD
Citalopram—Fatigue—Lisinopril—dilated cardiomyopathy	0.000677	0.000959	CcSEcCtD
Citalopram—Pain—Lisinopril—dilated cardiomyopathy	0.000672	0.000951	CcSEcCtD
Citalopram—Constipation—Lisinopril—dilated cardiomyopathy	0.000672	0.000951	CcSEcCtD
Citalopram—Vomiting—Furosemide—dilated cardiomyopathy	0.000666	0.000942	CcSEcCtD
Citalopram—Rash—Furosemide—dilated cardiomyopathy	0.00066	0.000934	CcSEcCtD
Citalopram—Dermatitis—Furosemide—dilated cardiomyopathy	0.000659	0.000934	CcSEcCtD
Citalopram—Headache—Furosemide—dilated cardiomyopathy	0.000656	0.000928	CcSEcCtD
Citalopram—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000647	0.000916	CcSEcCtD
Citalopram—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000642	0.000909	CcSEcCtD
Citalopram—Urticaria—Lisinopril—dilated cardiomyopathy	0.000624	0.000883	CcSEcCtD
Citalopram—Nausea—Furosemide—dilated cardiomyopathy	0.000622	0.00088	CcSEcCtD
Citalopram—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000621	0.000879	CcSEcCtD
Citalopram—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000621	0.000879	CcSEcCtD
Citalopram—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000579	0.000819	CcSEcCtD
Citalopram—Asthenia—Lisinopril—dilated cardiomyopathy	0.000563	0.000798	CcSEcCtD
Citalopram—Pruritus—Lisinopril—dilated cardiomyopathy	0.000556	0.000787	CcSEcCtD
Citalopram—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000537	0.000761	CcSEcCtD
Citalopram—Dizziness—Lisinopril—dilated cardiomyopathy	0.000519	0.000735	CcSEcCtD
Citalopram—Vomiting—Lisinopril—dilated cardiomyopathy	0.000499	0.000707	CcSEcCtD
Citalopram—Rash—Lisinopril—dilated cardiomyopathy	0.000495	0.000701	CcSEcCtD
Citalopram—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000495	0.0007	CcSEcCtD
Citalopram—Headache—Lisinopril—dilated cardiomyopathy	0.000492	0.000697	CcSEcCtD
Citalopram—Nausea—Lisinopril—dilated cardiomyopathy	0.000467	0.00066	CcSEcCtD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00014	0.00208	CbGpPWpGaD
Citalopram—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000136	0.00202	CbGpPWpGaD
Citalopram—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000135	0.00201	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000134	0.002	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000134	0.00199	CbGpPWpGaD
Citalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000133	0.00198	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000133	0.00197	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000131	0.00194	CbGpPWpGaD
Citalopram—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00013	0.00193	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00013	0.00193	CbGpPWpGaD
Citalopram—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00013	0.00193	CbGpPWpGaD
Citalopram—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000128	0.0019	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000126	0.00187	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000125	0.00186	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000122	0.00182	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000122	0.00182	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000121	0.0018	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000121	0.0018	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000121	0.0018	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000121	0.0018	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00012	0.00179	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000119	0.00177	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000119	0.00177	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000116	0.00173	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000116	0.00173	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000116	0.00172	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000116	0.00172	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000114	0.0017	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000114	0.0017	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000114	0.00169	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000113	0.00168	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000113	0.00168	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000112	0.00167	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000111	0.00164	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00011	0.00163	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00011	0.00163	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000109	0.00162	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000109	0.00162	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000109	0.00161	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000108	0.00161	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000108	0.0016	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000107	0.00159	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000102	0.00152	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000102	0.00152	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.0001	0.00149	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.95e-05	0.00148	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	9.84e-05	0.00146	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	9.57e-05	0.00142	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.57e-05	0.00142	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	9.44e-05	0.0014	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.33e-05	0.00139	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	9.32e-05	0.00139	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.3e-05	0.00138	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	9.25e-05	0.00137	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.15e-05	0.00136	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	9.12e-05	0.00136	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	9.12e-05	0.00136	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.93e-05	0.00133	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.85e-05	0.00132	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.82e-05	0.00131	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.68e-05	0.00129	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.62e-05	0.00128	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.61e-05	0.00128	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.59e-05	0.00128	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	8.54e-05	0.00127	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.46e-05	0.00126	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.44e-05	0.00126	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	8.36e-05	0.00124	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—RAF1—dilated cardiomyopathy	8.32e-05	0.00124	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	8.08e-05	0.0012	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	8.05e-05	0.0012	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	7.93e-05	0.00118	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.91e-05	0.00118	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.91e-05	0.00118	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	7.59e-05	0.00113	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	7.58e-05	0.00113	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	7.41e-05	0.0011	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	7.41e-05	0.0011	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	7.41e-05	0.0011	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.36e-05	0.00109	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.18e-05	0.00107	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.18e-05	0.00107	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	7.14e-05	0.00106	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.12e-05	0.00106	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	6.98e-05	0.00104	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	6.97e-05	0.00104	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.86e-05	0.00102	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.86e-05	0.00102	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.83e-05	0.00102	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.83e-05	0.00102	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.73e-05	0.001	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.73e-05	0.001	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.68e-05	0.000993	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.56e-05	0.000976	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	6.56e-05	0.000976	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.54e-05	0.000973	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.47e-05	0.000962	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	6.45e-05	0.000959	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	6.44e-05	0.000957	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	6.39e-05	0.00095	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.37e-05	0.000947	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.35e-05	0.000944	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	6.3e-05	0.000936	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.25e-05	0.00093	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.23e-05	0.000925	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.23e-05	0.000925	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.21e-05	0.000922	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.21e-05	0.000922	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.17e-05	0.000918	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.15e-05	0.000915	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.11e-05	0.000908	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.11e-05	0.000908	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.08e-05	0.000904	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.06e-05	0.0009	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	5.94e-05	0.000882	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.91e-05	0.000879	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.79e-05	0.00086	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.77e-05	0.000858	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.77e-05	0.000858	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.68e-05	0.000844	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.61e-05	0.000833	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.6e-05	0.000832	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.59e-05	0.000831	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	5.56e-05	0.000827	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	5.54e-05	0.000824	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.52e-05	0.000821	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	5.52e-05	0.000821	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.5e-05	0.000818	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	5.44e-05	0.000808	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.27e-05	0.000784	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.25e-05	0.000781	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.24e-05	0.000779	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.17e-05	0.000769	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.05e-05	0.00075	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	5.03e-05	0.000747	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5e-05	0.000743	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.99e-05	0.000741	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.91e-05	0.000729	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.79e-05	0.000712	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.78e-05	0.000711	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.77e-05	0.000709	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.7e-05	0.000698	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.56e-05	0.000678	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.54e-05	0.000675	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.53e-05	0.000673	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.48e-05	0.000666	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.47e-05	0.000665	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.46e-05	0.000662	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.29e-05	0.000638	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.28e-05	0.000636	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.24e-05	0.000631	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.24e-05	0.000631	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.14e-05	0.000616	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.13e-05	0.000614	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.07e-05	0.000605	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.06e-05	0.000604	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.95e-05	0.000586	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.94e-05	0.000585	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	3.89e-05	0.000578	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.88e-05	0.000577	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.88e-05	0.000577	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.87e-05	0.000575	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.84e-05	0.000571	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.83e-05	0.00057	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.82e-05	0.000568	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.81e-05	0.000566	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.71e-05	0.000551	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.7e-05	0.00055	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.68e-05	0.000547	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.68e-05	0.000547	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.67e-05	0.000545	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.67e-05	0.000545	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.66e-05	0.000544	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.64e-05	0.000541	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.61e-05	0.000536	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.61e-05	0.000536	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.53e-05	0.000524	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.51e-05	0.000522	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.46e-05	0.000514	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.45e-05	0.000513	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.42e-05	0.000508	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.41e-05	0.000507	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.37e-05	0.000501	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.36e-05	0.000499	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.35e-05	0.000499	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.31e-05	0.000492	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.31e-05	0.000491	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.3e-05	0.000491	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.26e-05	0.000485	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.25e-05	0.000483	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.1e-05	0.00046	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.07e-05	0.000456	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.99e-05	0.000444	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.83e-05	0.00042	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.82e-05	0.000419	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.78e-05	0.000412	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.7e-05	0.000401	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.69e-05	0.0004	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.68e-05	0.000399	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.67e-05	0.000398	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.66e-05	0.000395	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.63e-05	0.000391	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.4e-05	0.000357	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.34e-05	0.000348	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.33e-05	0.000346	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	2.32e-05	0.000345	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.31e-05	0.000343	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.3e-05	0.000342	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.3e-05	0.000341	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.29e-05	0.000341	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	2.27e-05	0.000338	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.26e-05	0.000336	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	2.26e-05	0.000336	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.22e-05	0.00033	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	2.21e-05	0.000329	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.08e-05	0.00031	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.08e-05	0.000309	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.04e-05	0.000304	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	2.03e-05	0.000302	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.99e-05	0.000296	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	1.99e-05	0.000296	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.98e-05	0.000295	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.95e-05	0.00029	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.85e-05	0.000275	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.75e-05	0.000261	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.71e-05	0.000254	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.71e-05	0.000254	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.67e-05	0.000248	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.61e-05	0.00024	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.6e-05	0.000238	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.6e-05	0.000238	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.59e-05	0.000237	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-05	0.000234	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.57e-05	0.000233	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.54e-05	0.000229	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.5e-05	0.000223	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	0.00021	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.38e-05	0.000205	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.38e-05	0.000205	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.37e-05	0.000203	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.36e-05	0.000201	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.33e-05	0.000198	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.2e-05	0.000178	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.09e-05	0.000162	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.05e-05	0.000157	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	0.000153	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.47e-06	0.000141	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.44e-06	0.00014	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	9.29e-06	0.000138	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.24e-06	0.000137	CbGpPWpGaD
